Softgel Capsules Global Market Opportunities And Strategies To 2034

The softgel capsules market is segmented by type into animal-based and non-animal-based. The animal-based market was the largest segment of the softgel capsules market segmented by type, accounting for 72.41% or $6.0 billion of the total in 2024. Going forward, the non-animal-based segment is expected to be the fastest growing segment in the softgel capsules market segmented by type, at a CAGR of 10.54% during 2024-2029.

The softgel capsules market is segmented by manufacturers into pharmaceutical companies, nutraceutical companies, cosmeceutical companies, contract manufacturing organizations. The nutraceutical companies market was the largest segment of the softgel capsules market segmented by manufacturers, accounting for 37.15% or $3.07 billion of the total in 2024. Going forward, the pharmaceutical companies segment is expected to be the fastest growing segment in the softgel capsules market segmented by manufacturers, at a CAGR of 9.54% during 2024-2029.

The softgel capsules market is segmented by application into antacid and anti-flatulent preparations, anti-anemic preparations, anti-inflammatory drugs, antibiotic and antibacterial drugs, cough and cold preparations, health supplement, vitamin and dietary supplement and pregnancy. The vitamin and dietary supplement market was the largest segment of the softgel capsules market segmented by application, accounting for 31.35% or $2.59 billion of the total in 2024. Going forward, the health supplement segment is expected to be the fastest growing segment in the softgel capsules market segmented by application, at a CAGR of 11.79% during 2024-2029.

North America was the largest region in the softgel capsules market, accounting for 42.25% or $3.5 billion of the total in 2024. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the softgel capsules market will be Asia Pacific and Eastern Europe where growth will be at CAGRs of 9.84% and 9.36% respectively. These will be followed by Middle East and South America where the markets are expected to grow at CAGRs of 9.21% and 9.08% respectively.

The global softgel capsules market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 29.82% of the total market in 2024. Catalent Inc. was the largest competitor with a 4.70% share of the market, followed by Aenova Group with 4.51%, Procaps Group SA with 3.20%, Sirio Pharma Co. Ltd. with 2.95%, Patheon with 2.94%, CAPTEK Softgel International Inc. with 2.86%, Strides Pharma Science Ltd. with 2.43%, Nitta Gelatin Inc. with 2.25%, Delpharm Holding SAS with 2.19% and Gelita AG with 1.79%.

The top opportunities in the softgel capsules market segmented by type will arise in the animal based segment, which will gain $8.89 billion of global annual sales by 2029. The top opportunities in the softgel capsules market segmented by manufacturers will arise in the nutraceutical companies segment, which will gain $4.76 billion of global annual sales by 2029. The top opportunities in the softgel capsules market segmented by application will arise in the health supplement segment, which will gain $3.66 billion of global annual sales by 2029. The softgel capsules market size will gain the most in the USA at $1.53 billion.

Market-trend-based strategies for the softgel capsules market include focus on forming strategic partnerships to develop advanced solutions, focus on developing innovative formulations that enhance therapeutic outcomes and user convenience, focus on developing innovative capsule shell systems, focus on developing innovative formulations targeting the pharmaceutical and over-the-counter (OTC) to sectors and focus on developing innovative, plant-based alternatives to traditional gelatin capsules.

This report describes and explains the softgel capsules market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global softgel capsules market reached a value of nearly $8.28 billion in 2024, having grown at a compound annual growth rate (CAGR) of 7.51% since 2019. The market is expected to grow from $8.28 billion in 2024 to $12.66 billion in 2029 at a rate of 8.86%. The market is then expected to grow at a CAGR of 8.93% from 2029 and reach $19.43 billion in 2034.

Growth in the historic period resulted from increasing geriatric population, increasing prevalence of chronic ailments and rising popularity of plant-based alternatives. Factors that negatively affected growth in the historic period was supply chain disruptions due to regulatory measures and high prices of raw materials.

Going forward, expanding pharmaceutical applications, growth of the cosmetic and personal care industry, growing awareness about health and wellness and favorable government initiatives will drive the growth. Factor that could hinder the growth of the softgel capsules market in the future include gelatin sourcing issues and limited shelf life.

Player-adopted strategies in the softgel capsules market include focus on expanding its business capabilities through innovative product.

To take advantage of the opportunities, the analyst recommends the softgel capsules companies to focus on innovation in formulation and bioavailability, focus on advancements in capsule shell systems, focus on innovative formulations for targeted health solutions, focus on plant-based alternatives for clean-label products, focus on non-animal based softgel capsules market, focus on pharmaceutical companies market, expand in emerging markets, focus on strategic partnerships for growth, focus on value-based and tiered pricing to drive competitive advantage, companies focus on targeted digital engagement for growth, focus on professional endorsement and scientific validation and focus on health supplement market.

This product will be delivered within 3-5 business days.